Evidence map›Paper›PMID 35336040›Full record

ArticlePharmaceutics2022

Image-Based Quantification of Gold Nanoparticle Uptake and Localization in 3D Tumor Models to Inform Radiosensitization Schedule.

Ljubica Z Petrovic, Michael Oumano, Justin Hanlon, Mark Arnoldussen, Igor Koruga, Sayeda Yasmin-Karim, Wilfred Ngwa, Jonathan Celli

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ljubica Z PetrovicDepartment of Physics, University of Massachusetts at Boston, Boston, MA 02125, USA.
Michael OumanoMedical Physics Program, Department of Physics and Applied Physics, University of Massachusetts Lowell, Lowell, MA 02125, USA.
Justin HanlonZEISS Group, Carl Zeiss Meditec, Inc., Dublin, CA 94568, USA.
Mark ArnoldussenZEISS Group, Carl Zeiss Meditec, Inc., Dublin, CA 94568, USA.
Igor KorugaZEISS Group, Carl Zeiss Meditec, Inc., Dublin, CA 94568, USA.
Sayeda Yasmin-KarimDana-Farber/Harvard Cancer Center, Boston, MA 02215, USA.
Wilfred NgwaMedical Physics Program, Department of Physics and Applied Physics, University of Massachusetts Lowell, Lowell, MA 02125, USA.
Jonathan CelliDepartment of Physics, University of Massachusetts at Boston, Boston, MA 02125, USA.ORCID 0000-0003-3560-0770
Carl Zeiss (United States) · USUniversity of Massachusetts Boston · USUniversity of Massachusetts Lowell · USDana-Farber/Harvard Cancer Center · US

Funding

Biomaterial Drones for Image-Guided Drug Delivery during radiotherapyR01CA239042 · NCI · JOHNS HOPKINS UNIVERSITY · PI NGWA, WILFRED · 2019 to 2023
$3.2M
Mechanism-based therapies for pancreatic cancer informed by stromal microrheologyR00CA155045 · NCI · UNIVERSITY OF MASSACHUSETTS BOSTON · PI CELLI, JONATHAN P · 2013 to 2015
$708k
NCI NIH HHS R00 CA155045NCI NIH HHS R01 CA239042NIH HHS R00CA155045 to JPC, and R01CA239042 to WN
6 · The paper itself

Abstract

Gold nanoparticles (GNPs) have shown particular promise as radiosensitizing agents and as complementary drug delivery agents to improve therapeutic index in cancer treatment. Optimal implementation, however, depends critically on the localization of GNPs at the time of irradiation, which, in turn, depends on their size, shape, and chemical functionalization, as well as organism-level pharmacokinetics and interactions with the tumor microenvironment. Here, we use in vitro 3D cultures of A549 lung carcinoma cells, which recapitulate interaction with extracellular matrix (ECM) components, combined with quantitative fluorescence imaging to study how time-dependent localization of ultrasmall GNPs in tumors and ECM impacts the degree of damage enhancement to tumor cells. Confocal imaging of fluorescence-labeled GNPs in 3D culture reveals that nanoparticles are initially embedded in ECM and only gradually accumulate in cancer cells over multiple days. Furthermore, the timing of GNP redistribution from ECM to cellular compartments directly impacts efficacy, with major damage enhancement when irradiation is performed after GNPs have accumulated significantly in 3D tumor nodules. These results underscore the importance of the timing and scheduling in treatment planning to ensure optimal radiosensitization, as well as the necessity of studying these effects in model systems that recapitulate elements of tumor microenvironment interaction.

Indexed as

3D tumor modelscancernanoparticlespharmacokineticsradiosensitization

Identifiers

PMID35336040
PMCPMC8953383
OpenAlexW4220667963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.